The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smirnova T.V.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Sheludchenko V.M.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Kozlovskaya N.L.

Department of Nephrology and Hemodialysis, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia;
Research Department of Nephrology, Research Center, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Kazarian É.É.

FGBU "NII glaznykh bolezneĭ" RAMN, Moskva

Andzhelova D.V.

FGBU "NII glaznykh bolezneĭ" RAMN

Sherstneva L.V.

I.M. Sechenov First Moscow State Medical University, Ophthalmology Department, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Velieva I.A.

FGBU "NII glaznykh bolezneĭ" RAMN

Kuchieva A.M.

I.M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Akaeva M.I.

I.M. Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991

Ocular thrombotic microangiopathy in atypical hemolytic-uremic syndrome (a clinical case study)

Authors:

Smirnova T.V., Sheludchenko V.M., Kozlovskaya N.L., Kazarian É.É., Andzhelova D.V., Sherstneva L.V., Velieva I.A., Kuchieva A.M., Akaeva M.I.

More about the authors

Journal: Russian Annals of Ophthalmology. 2018;134(5): 215‑226

Views: 680

Downloaded: 20


To cite this article:

Smirnova TV, Sheludchenko VM, Kozlovskaya NL, et al. . Ocular thrombotic microangiopathy in atypical hemolytic-uremic syndrome (a clinical case study). Russian Annals of Ophthalmology. 2018;134(5):215‑226. (In Russ.)
https://doi.org/10.17116/oftalma2018134051215

Recommended articles:
Expe­rience of using eculizumab in refractory myasthenia gravis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):85-90

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.